|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar
|
|
4
|
Ambros V: microRNAs: tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
7
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong C, Yao Y, Wang Y, et al:
Up-regulation of miR-21 mediates resistance to trastuzumab therapy
for breast cancer. J Biol Chem. 286:19127–19137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mei J, Bachoo R and Zhang CL:
MicroRNA-146a inhibits glioma development by targeting Notch1. Mol
Cell Biol. 31:3584–3592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suh SS, Yoo JY, Nuovo GJ, et al:
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc
Natl Acad Sci USA. 109:5316–5321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi P, Cheng SQ, Wang H, Li N, Chen YF and
Gao CF: Serum microRNAs as biomarkers for hepatocellular carcinoma
in Chinese patients with chronic hepatitis B virus infection. PLoS
One. 6:e284862011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dang X, Ma A, Yang L, et al: MicroRNA-26a
regulates tumorigenic properties of EZH2 in human lung carcinoma
cells. Cancer Genet. 205:113–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki H, Yamamoto E, Nojima M, et al:
Methylation-associated silencing of microRNA-34b/c in gastric
cancer and its involvement in an epigenetic field defect.
Carcinogenesis. 31:2066–2073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan K, Gao J, Yang T, et al: MicroRNA-34a
inhibits the proliferation and metastasis of osteosarcoma cells
both in vitro and in vivo. PLoS One. 7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Q, Jin H, Yang Z, et al: MiR-150
promotes gastric cancer proliferation by negatively regulating the
pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 392:340–345.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chow TF, Mankaruos M, Scorilas A, et al:
The miR-17–92 cluster is over expressed in and has an oncogenic
effect on renal cell carcinoma. J Urol. 183:743–751. 2010.
|
|
19
|
Deng S, Calin GA, Croce CM, Coukos G and
Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell
Cycle. 7:2643–2646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Slaby O, Svoboda M, Fabian P, et al:
Altered expression of miR-21, miR-31, miR-143 and miR-145 is
related to clinicopathologic features of colorectal cancer.
Oncology. 72:397–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hino K, Tsuchiya K, Fukao T, et al:
Inducible expression of microRNA-194 is regulated by HNF-1α during
intestinal epithelial cell differentiation. RNA. 14:1433–1442.
2008.PubMed/NCBI
|
|
24
|
Meng Z, Fu X, Chen X, et al: miR-194 is a
marker of hepatic epithelial cells and suppresses metastasis of
liver cancer cells in mice. Hepatology. 52:2148–2157. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krutzfeldt J, Rosch N, Hausser J,
Manoharan M, Zavolan M and Stoffel M: MicroRNA-194 is a target of
transcription factor 1 (Tcf1, HNF1α) in adult liver and controls
expression of frizzled-6. Hepatology. 55:98–107. 2012.PubMed/NCBI
|
|
26
|
Le XF, Almeida MI, Mao W, et al:
Modulation of MicroRNA-194 and cell migration by HER2-targeting
trastuzumab in breast cancer. PLoS One. 7:e411702012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hino K, Fukao T and Watanabe M: Regulatory
interaction of HNF1-α to microRNA-194 gene during intestinal
epithelial cell differentiation. Nucleic Acids Symp Ser (Oxf).
51:415–416. 2007.
|
|
28
|
Braun CJ, Zhang X, Savelyeva I, et al:
p53-Responsive micrornas 192 and 215 are capable of inducing cell
cycle arrest. Cancer Res. 68:10094–10104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song Y, Zhao F, Wang Z, et al: Inverse
association between miR-194 expression and tumor invasion in
gastric cancer. Ann Surg Oncol. 19(Suppl 3): S509–S517. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong P, Kaneuchi M, Watari H, et al:
MicroRNA-194 inhibits epithelial to mesenchymal transition of
endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer.
10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pichiorri F, Suh SS, Rocci A, et al:
Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs
the p53/ MDM2 autoregulatory loop in multiple myeloma development.
Cancer Cell. 18:367–381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen X, Yang TT, Wang W, et al:
Establishment and characterization of human osteosarcoma cell lines
with different pulmonary metastatic potentials. Cytotechnology.
61:37–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao G, Cai C, Yang T, et al: MicroRNA-221
induces cell survival and cisplatin resistance through PI3K/Akt
pathway in human osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun D, Yang K, Zheng G, Li Z and Cao Y:
Study on effect of peptide-conjugated near-infrared fluorescent
quantum dots on the clone formation, proliferation, apoptosis, and
tumorigenicity ability of human buccal squamous cell carcinoma cell
line BcaCD885. Int J Nanomed. 5:401–405. 2010. View Article : Google Scholar
|
|
35
|
Naito S, von Eschenbach AC, Giavazzi R and
Fidler IJ: Growth and metastasis of tumor cells isolated from a
human renal cell carcinoma implanted into different organs of nude
mice. Cancer Res. 46:4109–4115. 1986.PubMed/NCBI
|
|
36
|
Pan Z, Zhao W, Zhang X, et al: Scutellarin
alleviates interstitial fibrosis and cardiac dysfunction of infarct
rats by inhibiting TGFβ1 expression and activation of p38-MAPK and
ERK1/2. Br J Pharmacol. 162:688–700. 2011.PubMed/NCBI
|
|
37
|
Osaki M, Takeshita F, Sugimoto Y, et al:
MicroRNA-143 regulates human osteosarcoma metastasis by regulating
matrix metalloprotease-13 expression. Mol Ther. 19:1123–1130. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kong W, He L, Coppola M, et al:
MicroRNA-155 regulates cell survival, growth, and chemosensitivity
by targeting FOXO3a in breast cancer. J Biol Chem. 285:17869–17879.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grenman R, Burk D, Virolainen E, et al:
Clonogenic cell assay for anchorage-dependent squamous carcinoma
cell lines using limiting dilution. Int J Cancer. 44:131–136. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arndt CA, Rose PS, Folpe AL and Laack NN:
Common musculoskeletal tumors of childhood and adolescence. Mayo
Clin Proc. 87:475–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bacci G, Rocca M, Salone M, et al: High
grade osteosarcoma of the extremities with lung metastases at
presentation: treatment with neoadjuvant chemotherapy and
simultaneous resection of primary and metastatic lesions. J Surg
Oncol. 98:415–420. 2008. View Article : Google Scholar
|
|
42
|
Baffa R, Fassan M, Volinia S, et al:
MicroRNA expression profiling of human metastatic cancers
identifies cancer gene targets. J Pathol. 219:214–221. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lauvrak SU, Munthe E, Kresse SH, et al:
Functional characterisation of osteosarcoma cell lines and
identification of mRNAs and miRNAs associated with aggressive
cancer phenotypes. Br J Cancer. 109:2228–2236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miretti S, Roato I, Taulli R, et al: A
mouse model of pulmonary metastasis from spontaneous osteosarcoma
monitored in vivo by Luciferase imaging. PLoS One. 3:e18282008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Angst BD, Marcozzi C and Magee AI: The
cadherin superfamily: diversity in form and function. J Cell Sci.
114:629–641. 2001.PubMed/NCBI
|
|
46
|
Stemmler MP: Cadherins in development and
cancer. Mol Biosyst. 4:835–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dziadziuszko R, Merrick DT, Witta SE, et
al: Insulin-like growth factor receptor 1 (IGF1R) gene copy number
is associated with survival in operable non-small-cell lung cancer:
a comparison between IGF1R fluorescent in situ hybridization,
protein expression, and mRNA expression. J Clin Oncol.
28:2174–2180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Meyer F, Samson E, Douville P, Duchesne T,
Liu G and Bairati I: Serum prognostic markers in head and neck
cancer. Clin Cancer Res. 16:1008–1015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Munagala R, Aqil F and Gupta RC: Promising
molecular targeted therapies in breast cancer. Indian J Pharmacol.
43:236–245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
